BusinessOncoMed Presents Preclinical Data for Anti-TIGIT Program at the American Association for Cancer Research Annual Meeting 2017By Nasdaq OMXApr 3, 2017, 5:00 PM UTC
BusinessBiothera Announces Three Presentations at Upcoming American Association for Cancer Research (AACR) Annual MeetingBy Nasdaq OMXMar 27, 2017, 3:00 PM UTC
BusinessBiothera Pharmaceuticals to Discuss Imprime PGG Combination Therapy with Checkpoint Inhibitors at Molecular Medicine Tri-Conference 2017By Nasdaq OMXFeb 15, 2017, 3:26 PM UTC
BusinessBiothera Pharmaceuticals and Merck Further Expand Research Collaboration to Include Phase 2 Clinical Trial in Head and Neck CancerBy Nasdaq OMXDec 5, 2016, 2:30 PM UTC
BusinessOncoMed Initiates Phase 1b Immuno-Oncology Combination Clinical Trial for Demcizumab and Pembrolizumab (anti-PD1)By Nasdaq OMXMar 17, 2016, 12:30 PM UTC
